Company / Total Assets
Moderna Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$12.3B
FY2025
5-year range
$12.3B / $25.9B
FY2021-FY2025
Trend
-12.8%
vs FY2024
Sector context
#20 of 214
Health Care
What the data says
Among 214 Health Care companies, Moderna is in the top 9% for total assets. Total Assets has declined for 3 consecutive years, from $25.9B in FY2022 to $12.3B in FY2025.
Based on SEC 10-K filings.
$12.3B in FY2025 with a 5-year CAGR of +11.0%. Top quartile in the Health Care sector.
Declined from $18.4B to $12.3B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -21.9%
- 5-Year CAGR
- +11.0%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 214This company $12.3B Sector average $7.5B
▼
+65.2% above sector average
Key checks
Key Insights
- Moderna's total assets has declined for 3 consecutive years.
- 5-year CAGR of +11.0%, indicating consistent growth.
- In FY2025, total assets decreased 12.8% year-over-year.
- Ranks #20 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.3B | -12.8% |
| FY2024 | $14.1B | -23.2% |
| FY2023 | $18.4B | -28.7% |
| FY2022 | $25.9B | +4.8% |
| FY2021 | $24.7B | +236.2% |
| FY2020 | $7.3B | +361.6% |
| FY2019 | $1.6B | -19.0% |
| FY2018 | $2.0B | +80.9% |
| FY2017 | $1.1B | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026